4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-003899
CHIEF EXECUTIVE OFFICER bought 18,355 shares at $2.72 ($49,926)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-05-23 | Purchase | +18,355 | $2.72 | $49,926 | 5,191,873 | D |
| Open-market purchases · 18,355 sh · avg $2.72 · $49,926 | |||||||
Loading xslF345X03/ownership.xml…